Global Clinical Laboratory Services Market Report 2022: Market to Surpass $300 Billion by 2026 - Developed Regions Lead, Developing Economies Present Considerable Growth Opportunities
Global Market for Clinical Laboratory Services
Dublin, May 31, 2022 (GLOBE NEWSWIRE) -- The "Clinical Laboratory Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Clinical Laboratory Services Market to Reach $303.1 Billion by 2026
Amid the COVID-19 crisis, the global market for Clinical Laboratory Services estimated at US$222.7 Billion in the year 2020, is projected to reach a revised size of US$303.1 Billion by 2026, growing at a CAGR of 5.1% over the analysis period.
As Covid-19 financially disrupted healthcare organizations around the world, clinical laboratories of all sizes played a vital role in response to the pandemic by ramping up capacity to meet the increased demand for Covid-19 testing. The Covid-19 outbreak placed unprecedented demands on healthcare system in various countries with challenges of supply chain disruptions and heightened demand on health facilities.
The accelerated pace at which the novel coronavirus spread around the world saturated hospital capacity and exposed the deficiencies in the public health system. The pandemic highlighted the critical role of diagnostic testing in outbreak control. As governments and health authorities around the world sought ways to increase access to reliable testing to screen for the disease, the amplified global demand for Covid-19 test kits led to shortages of laboratory-based molecular testing.
Given the urgent global need for rapid, point-of-care diagnostic tests to deal with the continuous spread of the Covid-19 pandemic, rapid testing emerged as a vital tool to meet the unprecedented demand.
Clinical Chemistry, one of the segments analyzed in the report, is projected to grow at a 4.8% CAGR to reach US$138 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Human & Tumor Genetics segment is readjusted to a revised 4.7% CAGR for the next 7-year period. This segment currently accounts for a 21.6% share of the global Clinical Laboratory Services market.
The U.S. Market is Estimated at $112.1 Billion in 2021, While China is Forecast to Reach $11.7 Billion by 2026
The Clinical Laboratory Services market in the U.S. is estimated at US$112.1 Billion in the year 2021. The country currently accounts for a 47.38% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$11.7 Billion in the year 2026 trailing a CAGR of 7.3% through the analysis period.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR while Rest of European market (as defined in the study) will reach US$12.5 Billion by the close of the analysis period.
The market will continue to experience significant growth worldwide due to recent developments in diagnostic techniques, growth in the geriatric population and due to the growth of chronic diseases. The need to reduce hospital readmission rates and reducing hospitalization time has increased in the recent years, leading to increased compliance for diagnostic services among healthcare providers.
Increasing patient awareness of disease diagnosis, climate change, growing prosperity of emerging markets, evolution to pathogens, advanced in the area of biotechnology in proteomics and genomics, and advances in interoperability and automation are driving the market for clinical laboratory services.
Technological advancements are also driving market growth. Novel test areas such as genetic tests, companion diagnostics and molecular testing are witnessing significant growth and generating sizable revenues and margins for labs providing them. Advancements in molecular biology and genomics are yielding more advanced and accurate tests for various indications leading to their adoption.
Medical Microbiology & Cytology Segment to Reach $66.2 Billion by 2026
In the global Medical Microbiology & Cytology segment, USA, Canada, Japan, China and Europe will drive the 7.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$38.9 Billion in the year 2020 will reach a projected size of US$62.8 Billion by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2026, while Latin America will expand at a 8% CAGR through the analysis period.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of COVID-19 Pandemic and Looming Global Recession
Clinical Laboratories Step Up Strategies for Protecting Personnel
Assays for COVID-19 Detection
Clinical Labs Benefit from the Surge in COVID-19 Testing Volumes
Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of December 8th, 2020
COVID-19 Affects Fortunes of Non-COVID Diagnostics
Cancer Testing Dives During First Half of 2020
Labs Embark New Journeys to Retain Overall Volumes
At Home Testing Presents Challenges for Clinical Lab Services
An Introduction to Clinical Laboratory Services
Types of Tests Conducted in Medical Labs
Types of Clinical Laboratories
Global Market Prospects & Outlook
Hospital-based Laboratories Lead the Global Market
Developed Regions Lead, Developing Economies Present Considerable Growth Opportunities
Competition
Consolidation Activity Gathers Pace
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS (Total 125 Featured)
ADICON Clinical Laboratories, Inc.
ARUP Laboratories
Bio-Reference Laboratories, Inc.
DaVita, Inc.
Enzo Clinical Labs
Genova Diagnostics, Inc.
Kingmed Diagnostics
Laboratory Corporation of America Holdings
Dynacare
Mayo Clinic Laboratories
NeoGenomics Laboratories
Genoptix, Inc.
Quest Diagnostics, Inc.
Sonic Healthcare Limited
Bioscientia Institut fur Medizinische Diagnostik GmbH
American Esoteric Laboratories
SYNLAB International GmbH
The National Health Laboratory Service
Thyrocare Technologies Limited
Unilabs SA
3. MARKET TRENDS & DRIVERS
Rising Healthcare Needs of Aging Population to Boost Demand for Laboratory Services
Increasing Incidence of Chronic Diseases Drives the World Clinical Laboratory Services Market
Rise in Healthcare Expenditure to Drive Growth
With COVID-19 Highlighting the Threat Posed by Infectious Diseases, Role of Clinical Labs in Testing Infectious Diseases Grows in Importance
Infectious Diseases Remain Major Cause of Death in Under Developed Regions
Increasing Prevalence of Respiratory Infections Drive Growth
Lab Automation Speeds Up
Rise of Laboratory 4.0 Transforms Clinical Laboratory Space
Laboratory Information Systems Gain Traction amidst Growing Need to Enhance Workflow Efficiencies and Reduce Costs
Artificial Intelligence: The Future of LIMS
Digitalization, Automation and AI Trends Shape Growth
Microbiology Laboratories Switch to Automation to Push Yields
Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
Integration of Clinical Microbiology with Cloud Computing
Advent of New & Advanced Devices Fuels Growth in Clinical Laboratory Services Market
New Technologies and Tests Drive Demand for Specific Testing
Increasing Role of Advanced Tests in Clinical Treatment Decision Making
Innovations Hold Potential to Improve Clinical Chemistry Lab Performance
Disruptive Innovations in Clinical Lab Space Present Growth Opportunities
Increasing Opportunities in Personalized Medicine and Clinical Trial Services
Autoimmune Disease Testing: Labs Seek Cost-Effective & High Productivity Options
Genetic Disease Testing Offers Bright Prospects for Lab Services
Reduced Hospitalization Enhances Significance of Medical Labs
Standardization Gains Precedence in the Hunt for Automation
Assessing the Impact of Point-of-Care Testing on Clinical Labs
Hospital Laboratories to Transform into Profit Centers
Hospital Outreach Laboratories Deliver Better Value to Larger Organizations
Physician Office Laboratories: Focus on Reducing Turnaround Times for Testing
Emerging Clinical Laboratory Designs Focus on Improving Space Utilization and Promote Healthy Work Environments
Laboratory Outsourcing Trend Gains Strength
Challenges Facing Lab Testing Market
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/h69gpe
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900